{"id":1943,"date":"2020-03-18T00:00:00","date_gmt":"2020-03-18T00:00:00","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=1943"},"modified":"2021-02-26T13:35:53","modified_gmt":"2021-02-26T13:35:53","slug":"descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/","title":{"rendered":"Descobreix la primera cohort de projectes CaixaImpulse Consolidate"},"content":{"rendered":"<div class=\"post_content\">\n<p dir=\"ltr\"><img decoding=\"async\" style=\"width: 400px; height: 400px;\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg\" alt=\"\" \/><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-e56f20dc-7fff-de59-785a-3f6c95e7401f\">Si llegeixes qualsevol revista cient\u00edfica no trigar\u00e0s a trobar articles sobre edici\u00f3 gen\u00e8tica, medicina personalitzada i resist\u00e8ncia als antibi\u00f2tics. Les dues primeres q\u00fcestions estan transformant cada vegada m\u00e9s l\u2019assist\u00e8ncia sanit\u00e0ria, fet que ens permet entendre les complexitats de diverses malalties que en un moment donat es van considerar irresolubles i, per tant, tractar-les. Ara b\u00e9, la tercera q\u00fcesti\u00f3 amena\u00e7a deixar sense efecte moltes opcions terap\u00e8utiques fiables, a m\u00e9s d\u2019imposar una c\u00e0rrega sense precedents als sistemes sanitaris d\u2019arreu del m\u00f3n.<\/span><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-e56f20dc-7fff-de59-785a-3f6c95e7401f\">Aquests s\u00f3n els principals temes que investiguen, de forma innovadora, els quatre projectes seleccionats a l\u2019edici\u00f3 inaugural de <\/span><a href=\"https:\/\/caixaimpulse.com\/en\/programme?program_id=PROGRAMME\" target=\"_blank\" rel=\"noopener noreferrer\">CaixaImpulse Consolidate<\/a>. Tots ofereixen solucions a necessitats biom\u00e8diques que encara no han estat cobertes, i rebran fins a 300.000 \u20ac i suport essencial per acostar els seus actius al mercat i als pacients.<\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-e56f20dc-7fff-de59-785a-3f6c95e7401f\">Tot i que no \u00e9s un requisit previ de la convocat\u00f2ria Consolidate, els quatre projectes havien estat seleccionats en una edici\u00f3 anterior de <\/span><a href=\"https:\/\/caixaimpulse.com\/programme?program_id=PROGRAMME_VALIDATE&amp;program_section=OVERVIEW\" target=\"_blank\" rel=\"noopener noreferrer\">CaixaImpulse Validate<\/a> i ara estan preparats per avan\u00e7ar cap a una etapa de captaci\u00f3 de fons. Descobreix la primera cohort.<\/p>\n<p dir=\"ltr\"><strong>Curar l\u2019at\u00e0xia de Friedreich amb ter\u00e0pia g\u00e8nica<\/strong><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-e56f20dc-7fff-de59-785a-3f6c95e7401f\">L\u2019at\u00e0xia de Friedreich (FRDA) \u00e9s una malaltia neurodegenerativa incurable que se sol manifestar durant la infantessa i afecta aproximadament 1 de cada 50.000 persones. L\u2019objectiu del projecte <a href=\"https:\/\/caixaimpulse.com\/en_US\/projects\/-\/caixaimpulse\/project\/254226\" target=\"_blank\" rel=\"noopener noreferrer\">FRATAXAV<\/a>, dirigit per Antoni Matilla, de l\u2019<\/span><a href=\"http:\/\/www.germanstrias.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">Institut d\u2019Investigaci\u00f3 Germans Trias i Pujol<\/a> (IGTP), \u00e9s desenvolupar un tractament curatiu per a aquesta malaltia devastadora. Aquest innovador f\u00e0rmac proporcionar\u00e0 frataxina, una prote\u00efna que disminueix a la FRDA, a les c\u00e8l\u00b7lules dels pacients mitjan\u00e7ant un vector viral adenoassociat recombinant. L\u2019any passat vam parlar amb Antoni Matilla en el Dia de les Malalties Rares per debatre els aven\u00e7os del projecte i la import\u00e0ncia de conscienciar sobre aquestes malalties. En pots llegir l\u2019entrevista <a href=\"https:\/\/caixaimpulse.com\/en_US\/news-events\/-\/caixaimpulse\/news\/127296\" target=\"_blank\" rel=\"noopener noreferrer\">aqu\u00ed<\/a>.<\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-867e4a66-7fff-e2aa-6e41-714775897d9d\"><img decoding=\"async\" style=\"width: 400px; height: 215px;\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/GrupAntoniMatilla2812928129.jpg\" alt=\"\" \/><\/span><br \/>\n<span style=\"font-size: 11px;\">L\u2019equip del projecte FRATAXAV, dirigit per Antoni Matilla (dreta)<\/span><\/p>\n<p dir=\"ltr\"><strong>Edici\u00f3 gen\u00e8tica per combatre la distr\u00f2fia muscular de tipus 1A<\/strong><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-6e0c7707-7fff-1bc9-11ce-3ebea72cc586\">Les tecnologies actuals d\u2019edici\u00f3 gen\u00e8tica tenen certes limitacions. Per exemple, resulta complicat administrar ter\u00e0pies de substituci\u00f3 g\u00e8nica mitjan\u00e7ant vectors virals quan la prote\u00efna diana \u00e9s massa gran. Marc G\u00fcell i el seu equip a la <\/span><a href=\"https:\/\/www.upf.edu\/home\" target=\"_blank\" rel=\"noopener noreferrer\">Universitat Pompeu Fabra<\/a> (UPF) esperen resoldre aquest problema amb el projecte propi <a href=\"https:\/\/caixaimpulse.com\/en_US\/projects\/-\/caixaimpulse\/project\/254148\" target=\"_blank\" rel=\"noopener noreferrer\">Uni-Large<\/a>. El seu enfocament, que combina la precisi\u00f3 de CRISPR amb l\u2019efectivitat dels vectors virals, es far\u00e0 servir per tractar la distr\u00f2fia muscular cong\u00e8nita de tipus 1 (MDC1A), una malaltia rara incurable que es manifesta en n\u00e9ixer.<\/p>\n<p dir=\"ltr\"><img decoding=\"async\" style=\"width: 400px; height: 213px;\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/GrupMarcGuell28129.JPG.jpg\" alt=\"\" \/><br \/>\n<span style=\"font-size: 11px;\">El grup de Biologia Sint\u00e8tica Traslacional a la UPF, que desenvolupa la plataforma d\u2019edici\u00f3 g\u00e8nica Uni-Large<\/span><\/p>\n<p dir=\"ltr\"><strong>Permetre la medicina personalitzada en el c\u00e0ncer<\/strong><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-dd046e52-7fff-3065-4de4-fc6e4d616d76\">El c\u00e0ncer ja \u00e9s summament dif\u00edcil de tractar i, sovint, es complica encara m\u00e9s per les diferents respostes dels pacients a certs f\u00e0rmacs. Aix\u00f2 \u00e9s el que ocorre amb els inhibidors de PARP, una fam\u00edlia de f\u00e0rmacs utilitzats per tractar determinats tipus de c\u00e0ncer de mama i d\u2019ovari. Alba Llop, investigadora al <\/span><a href=\"https:\/\/www.vhio.net\/ca\/\" target=\"_blank\" rel=\"noopener noreferrer\">Vall d\u2019Hebron Institut d\u2019Oncologia<\/a> (VHIO), dirigeix el projecte <a href=\"https:\/\/caixaimpulse.com\/en_US\/projects\/-\/caixaimpulse\/project\/253873\" target=\"_blank\" rel=\"noopener noreferrer\">RAD51predict<\/a>. El seu objectiu \u00e9s desenvolupar una prova diagn\u00f2stica per determinar quins pacients es podran beneficiar dels inhibidors de PARP i, aix\u00ed, oferir un tractament m\u00e9s personalitzat.<\/p>\n<p dir=\"ltr\"><img decoding=\"async\" style=\"width: 400px; height: 235px;\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/GrupAlbaLlop2812928129.jpg\" alt=\"\" \/><br \/>\n<span style=\"font-size: 11px;\">Alba Llop (tercera des de l\u2019esquerra) \u00e9s la directora de RAD51predict, un projecte de VHIO<\/span><\/p>\n<p dir=\"ltr\"><strong>Combatre la resist\u00e8ncia als antibi\u00f2tics amb un f\u00e0rmac que refor\u00e7a la immunitat<\/strong><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-3a9e2175-7fff-774e-4e97-e83b15d8d62f\">Les infeccions intrahospital\u00e0ries s\u00f3n un problema greu als sistemes sanitaris d\u2019arreu del m\u00f3n. Els bacteris gramnegatius s\u00f3n responsables de fins al 30 % d\u2019aquestes infeccions, i desenvolupen r\u00e0pidament una resist\u00e8ncia als antibi\u00f2tics disponibles. El projecte <a href=\"https:\/\/caixaimpulse.com\/en_US\/projects\/-\/caixaimpulse\/project\/254176\" target=\"_blank\" rel=\"noopener noreferrer\">RemAb Therapeutics<\/a>, una <\/span>spin-off de l\u2019<a href=\"http:\/\/www.idibell.cat\/en\" target=\"_blank\" rel=\"noopener noreferrer\">Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge<\/a> (IDIBELL) dirigit per Rafael M\u00e1\u00f1ez, ofereix una alternativa que no genera resist\u00e8ncia. Aquest f\u00e0rmac, RA-01, elimina els anticossos no neutralitzants i, per tant, refor\u00e7a la resposta immune del pacient per evitar l\u2019aparici\u00f3 d\u2019infeccions. Pots llegir l\u2019entrevista que vam fer el 2019 a Rafael M\u00e1\u00f1ez\u00a0<span id=\"docs-internal-guid-3a9e2175-7fff-774e-4e97-e83b15d8d62f\"><a href=\"https:\/\/caixaimpulse.com\/en_US\/news-events\/-\/caixaimpulse\/news\/128201\" target=\"_blank\" rel=\"noopener noreferrer\">aqu\u00ed<\/a><\/span>.<\/p>\n<p dir=\"ltr\"><img decoding=\"async\" style=\"width: 400px; height: 246px;\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/RemAbgroup28129.jpeg\" alt=\"\" \/><br \/>\n<span id=\"docs-internal-guid-140d28ec-7fff-627b-73fe-e5f0438436e0\"><a href=\"https:\/\/remabtx.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">RemAb Therapeutics<\/a><\/span> \u00e9s una <em>spin-off<\/em> d\u2019IDIBELL, dirigit pel Rafael M\u00e1\u00f1ez<\/p>\n<p dir=\"ltr\">\n<p dir=\"ltr\"><em>Aquest article tamb\u00e9 apareix a la <a href=\"https:\/\/caixaimpulse.com\/en-US\/web\/guest\/news-events\/-\/caixaimpulse\/news\/249805\" target=\"_blank\" rel=\"noopener\">p\u00e0gina web de CaixaImpulse<\/a>.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p dir=\"ltr\"><img decoding=\"async\" style=\"width: 400px; height: 400px;\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg\" alt=\"\" \/><\/p>\n<p dir=\"ltr\">Si llegeixes qualsevol revista cient\u00edfica no trigar\u00e0s a trobar articles sobre edici\u00f3 gen\u00e8tica, medicina personalitzada i resist\u00e8ncia als antibi\u00f2tics. Les dues primeres q\u00fcestions estan transformant cada vegada m\u00e9s l\u2019assist\u00e8ncia sanit\u00e0ria, fet que ens permet entendre les complexitats de diverses malalties que en un moment donat es van considerar irresolubles i, per tant, tractar-les. Ara b\u00e9, la tercera q\u00fcesti\u00f3 amena\u00e7a deixar sense efecte moltes opcions terap\u00e8utiques fiables, a m\u00e9s d\u2019imposar una c\u00e0rrega sense precedents als sistemes sanitaris d\u2019arreu del m\u00f3n.<\/p>\n<p dir=\"ltr\">Aquests s\u00f3n els principals temes que investiguen, de forma innovadora, els quatre projectes seleccionats a l\u2019edici\u00f3 inaugural de <a href=\"https:\/\/caixaimpulse.com\/en\/programme?program_id=PROGRAMME\" target=\"_blank\" rel=\"noopener noreferrer\">CaixaImpulse Consolidate<\/a>. Tots ofereixen solucions a necessitats biom\u00e8diques que encara no han estat cobertes,<\/p>\n","protected":false},"author":1,"featured_media":3129,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[519],"tags":[10,349,350,13],"class_list":["post-1943","post","type-post","status-publish","format-standard","hentry","category-investigacio","tag-caixaimpulse","tag-edicio-genica","tag-medicina-personalitzada","tag-resistencia-antimicrobiana"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Descobreix la primera cohort de projectes CaixaImpulse Consolidate - Blog CaixaCi\u00e8ncia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Descobreix la primera cohort de projectes CaixaImpulse Consolidate - Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"og:description\" content=\"Si llegeixes qualsevol revista cient\u00edfica no trigar\u00e0s a trobar articles sobre edici\u00f3 gen\u00e8tica, medicina personalitzada i resist\u00e8ncia als antibi\u00f2tics. Les dues primeres q\u00fcestions estan transformant cada vegada m\u00e9s l\u2019assist\u00e8ncia sanit\u00e0ria, fet que ens permet entendre les complexitats de diverses malalties que en un moment donat es van considerar irresolubles i, per tant, tractar-les. Ara b\u00e9, la tercera q\u00fcesti\u00f3 amena\u00e7a deixar sense efecte moltes opcions terap\u00e8utiques fiables, a m\u00e9s d\u2019imposar una c\u00e0rrega sense precedents als sistemes sanitaris d\u2019arreu del m\u00f3n. Aquests s\u00f3n els principals temes que investiguen, de forma innovadora, els quatre projectes seleccionats a l\u2019edici\u00f3 inaugural de CaixaImpulse Consolidate. Tots ofereixen solucions a necessitats biom\u00e8diques que encara no han estat cobertes,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-18T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-26T13:35:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"La Caixa\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"La Caixa\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/\",\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/\",\"name\":\"Descobreix la primera cohort de projectes CaixaImpulse Consolidate - Blog CaixaCi\u00e8ncia\",\"isPartOf\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg\",\"datePublished\":\"2020-03-18T00:00:00+00:00\",\"dateModified\":\"2021-02-26T13:35:53+00:00\",\"author\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/c4ed33a98e6581c876664e7035da245a\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/#primaryimage\",\"url\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg\",\"contentUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg\",\"width\":800,\"height\":800},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\",\"url\":\"https:\/\/blog.caixaresearch.org\/\",\"name\":\"Blog CaixaCi\u00e8ncia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.caixaresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/c4ed33a98e6581c876664e7035da245a\",\"name\":\"La Caixa\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d49b93050814699a8c78e1e6223735d5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d49b93050814699a8c78e1e6223735d5?s=96&d=mm&r=g\",\"caption\":\"La Caixa\"},\"sameAs\":[\"https:\/\/blog.caixaresearch.org\"],\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/author\/caixaciencialamagnetica-net\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Descobreix la primera cohort de projectes CaixaImpulse Consolidate - Blog CaixaCi\u00e8ncia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/","og_locale":"ca_ES","og_type":"article","og_title":"Descobreix la primera cohort de projectes CaixaImpulse Consolidate - Blog CaixaCi\u00e8ncia","og_description":"Si llegeixes qualsevol revista cient\u00edfica no trigar\u00e0s a trobar articles sobre edici\u00f3 gen\u00e8tica, medicina personalitzada i resist\u00e8ncia als antibi\u00f2tics. Les dues primeres q\u00fcestions estan transformant cada vegada m\u00e9s l\u2019assist\u00e8ncia sanit\u00e0ria, fet que ens permet entendre les complexitats de diverses malalties que en un moment donat es van considerar irresolubles i, per tant, tractar-les. Ara b\u00e9, la tercera q\u00fcesti\u00f3 amena\u00e7a deixar sense efecte moltes opcions terap\u00e8utiques fiables, a m\u00e9s d\u2019imposar una c\u00e0rrega sense precedents als sistemes sanitaris d\u2019arreu del m\u00f3n. Aquests s\u00f3n els principals temes que investiguen, de forma innovadora, els quatre projectes seleccionats a l\u2019edici\u00f3 inaugural de CaixaImpulse Consolidate. Tots ofereixen solucions a necessitats biom\u00e8diques que encara no han estat cobertes,","og_url":"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/","og_site_name":"Blog CaixaCi\u00e8ncia","article_published_time":"2020-03-18T00:00:00+00:00","article_modified_time":"2021-02-26T13:35:53+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg","type":"image\/jpeg"}],"author":"La Caixa","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"La Caixa","Temps estimat de lectura":"4 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/","url":"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/","name":"Descobreix la primera cohort de projectes CaixaImpulse Consolidate - Blog CaixaCi\u00e8ncia","isPartOf":{"@id":"https:\/\/blog.caixaresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/#primaryimage"},"image":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg","datePublished":"2020-03-18T00:00:00+00:00","dateModified":"2021-02-26T13:35:53+00:00","author":{"@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/c4ed33a98e6581c876664e7035da245a"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/ca\/descobreix-la-primera-cohort-de-projectes-caixaimpulse-consolidate\/#primaryimage","url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg","contentUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/04\/Card_CIConsProjects_CAT28129.jpg","width":800,"height":800},{"@type":"WebSite","@id":"https:\/\/blog.caixaresearch.org\/#website","url":"https:\/\/blog.caixaresearch.org\/","name":"Blog CaixaCi\u00e8ncia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.caixaresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/c4ed33a98e6581c876664e7035da245a","name":"La Caixa","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d49b93050814699a8c78e1e6223735d5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d49b93050814699a8c78e1e6223735d5?s=96&d=mm&r=g","caption":"La Caixa"},"sameAs":["https:\/\/blog.caixaresearch.org"],"url":"https:\/\/blog.caixaresearch.org\/ca\/author\/caixaciencialamagnetica-net\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/1943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/comments?post=1943"}],"version-history":[{"count":4,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/1943\/revisions"}],"predecessor-version":[{"id":4265,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/1943\/revisions\/4265"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/media\/3129"}],"wp:attachment":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/media?parent=1943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/categories?post=1943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/tags?post=1943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}